Validation of the 2017 European LeukemiaNet classification for acute myeloid leukemia with NPM1 and FLT3-internal tandem duplication genotypes.
Prajwal C BodduTapan Mahendra KadiaGuillermo Garcia-ManeroJorge CortesMansour AlfayezGautam BorthakurMarina KonoplevaElias J JabbourNaval G DaverCourtney D DiNardoKiran NaqviMusa YilmazNicholas J ShortSherry PierceHagop M KantarjianFarhad RavandiPublished in: Cancer (2018)
The ELN-2017 more accurately distinguishes prognosis in patients with newly diagnosed AML. The lack of prognostic significance for the FLT3-ITD AR needs further evaluation in different treatment settings.